What is Brawn Biotech Ltd (530207) share price return in the past 10 years?

Brawn Biotech Ltd share price has declined -5.4% annually (CAGR) over the past ten years.

What is the share price of Brawn Biotech Ltd (530207)?

Company share prices are keep on changing according to the market conditions. The current trading price of Brawn Biotech Ltd (530207) on 12-Jun-2026 16:59:59 at 16:59 is 19.50.

What is the P/E ratio of Brawn Biotech?

The latest standalone P/E ratio of Brawn Biotech as of 12-Jun-2026 is 6.22.

What is the P/B ratio of Brawn Biotech Ltd (530207)?

The latest standalone P/B ratio of Brawn Biotech Ltd (530207) as of 12-Jun-2026 is 1.35.

What is the 52-week high and low of Brawn Biotech Ltd (530207)?

The 52-week high of Brawn Biotech Ltd (530207) is Rs. 24.37 and the 52-week low is Rs. 16.15.

Brawn Biotech Ltd (530207) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Brawn Biotech Ltd (530207)
Brand: Brawn Biotech

Brawn Biotech Ltd (530207)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530207 NSE: Trading | Small Cap | Brawn Biotech Share Price

Brawn Biotech Ltd (530207)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530207 NSE: Trading | Small Cap | Brawn Biotech Share Price

Key Metrics

Valuation Multiples

Market Cap

₹6 Cr.

Current Price

₹19.5

52-Week Low / High

₹16 / 24

TTM EPS

₹3.1

TTM Sales

₹17 Cr.

Book Value per Share

₹14.5

P/E Ratio

6.22

Industry PE

35.6

Price to Book (P/B)

1.35

Higher than its 5-year historical median

Price to Sales (P/S)

0.34

In line with its 5-year historical median

EV/EBITDA

43.51

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-41.30%

Underperforms industry median

Return on Capital Employed (ROCE)

-42.59%

Underperforms industry median

Return on Assets (ROA)

-10.20%

Operating Profit Margin

-13.2%

Net Profit Margin

-12.92%

Gross Profit Margin

-12.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-18.31%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

52.94%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹1 Cr.

Equity

₹3 Cr.

Face Value

₹10

All Time Low / High

₹0.40 / 95.60

Brawn Biotech stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Brawn Biotech Ltd a good quality company?

Brawn Biotech Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Brawn Biotech Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Brawn Biotech Ltd vs industry peers?

Brawn Biotech Ltd revenue CAGR is -22.96%, compared to the industry median CAGR of 0%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Brawn Biotech Ltd?

Promoters hold 52.94% of the Brawn Biotech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Brawn Biotech Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -7.3% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	26.4%	29%	27.8%	23%	9.7%	-3.6%	-25.7%	-5.9%	-26.1%	-42.6%	-
Value Creation Index ⓘ	0.9	1.1	1.0	0.7	-0.3	-1.3	-2.8	-1.4	-2.9	-4.0	-
Growth Parameters ⓘ
Sales ⓘ	46.9	60.6	55.8	65.2	49.6	35	8.6	22.2	16.5	13.5	17
Sales YoY Gr.	-	29.2%	-7.9%	16.9%	-23.9%	-29.5%	-75.4%	157.9%	-25.8%	-18.3%	-
Adj EPS ⓘ	3.3	3.3	4.2	4.1	1.8	-2.5	-5.5	-2.9	-4.1	-5.8	3.1
YoY Gr.	-	0.3%	26.3%	-1%	-57.7%	-241.1%	NA	NA	NA	NA	-
BVPS (₹) ⓘ	18.4	23.1	25.4	28.9	30.9	29.3	24.1	21	16.9	11.2	14.5
Adj Net Profit ⓘ	1	1	1.3	1.2	0.5	-0.7	-1.7	-0.9	-1.2	-1.7	1
Cash Flow from Ops. ⓘ	0.1	1.4	-1.5	0.2	-0.1	0	0.2	0.3	-0	0.1	-
Debt/CF from Ops. ⓘ	2.4	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-12.9%	-23%	16%	-18.3%
Adj EPS ⓘ	-206.5%	-227.1%	NA	NA
BVPSⓘ	-5.4%	-18.3%	-22.5%	-33.6%
Share Price	-5.4%	-4.4%	9.1%	14.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	18.9	15.9	17.2	15.3	5.9	-8.2	-20.6	-12.8	-21.8	-41.3	24.5
Op. Profit Mgn % ⓘ	3.2	2.1	3.5	1.8	1.5	-1.7	-23.3	-1.4	-8.9	-13.2	-1.9
Net Profit Mgn % ⓘ	2.1	1.6	2.3	1.9	1.1	-2.1	-19.1	-3.9	-7.5	-12.9	5.6
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	105	85	120	122	152	171	545	214	298	443	293
Cash Conv. Cycle ⓘ	28	31	32	27	46	70	274	57	99	185	35

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	46.88	60.55	55.78	65.18	49.62	34.98	8.62	22.23	16.49	13.46
Operating Expenses ⓘ +	45.45	59.31	53.82	64.01	48.88	35.57	10.63	22.53	17.97	15.24
Manufacturing Costs	0.20	0.06	0.06	0.08	1.28	1.41	0.19	0.34	0.20	0.12
Material Costs	40.52	52.19	48.85	58.50	42.10	30.02	6.59	19.18	14.36	11.93
Employee Cost	1.86	1.98	2.98	3.02	3.08	2.36	1.80	1.40	1.40	1.13
Other Costs ⓘ	2.86	5.08	1.93	2.41	2.41	1.78	2.04	1.62	2.01	2.06
Operating Profit ⓘ	1.44	1.24	1.96	1.17	0.74	-0.60	-2.01	-0.30	-1.47	-1.77
Operating Profit Margin (%)	3.1%	2.0%	3.5%	1.8%	1.5%	-1.7%	-23.3%	-1.4%	-8.9%	-13.2%
Other Income ⓘ +	0.01	0.62	0.09	0.74	0.17	0.31	0	0.01	0.09	0.09
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.11	0.07	0.06	0.07	0.05	0.04	0.06	0.01	0.06	0
Depreciation ⓘ	0.03	0.03	0.03	0.03	0.03	0.03	0.05	0.11	0.10	0.11
Profit Before Tax ⓘ	1.30	1.76	1.96	1.81	0.82	-0.36	-2.12	-0.41	-1.54	-1.80
Tax ⓘ	0.36	0.36	0.68	0.47	0.23	0.19	-0.47	0.46	-0.30	-0.06
Profit After Tax	0.95	1.39	1.28	1.33	0.59	-0.55	-1.64	-0.87	-1.25	-1.74
PAT Margin (%)	2.0%	2.3%	2.3%	2.0%	1.2%	-1.6%	-19.1%	-3.9%	-7.6%	-12.9%
Adjusted EPS (₹)	3.2	4.6	4.3	4.4	2.0	-1.8	-5.5	-2.9	-4.2	-5.8
Dividend Payout Ratio (%)	31.60%	32.30%	23.40%	0%	0%	0%	0%	0%	0%	0%

Valuation of Brawn Biotech - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5.53	6.92	7.63	8.66	9.26	8.80	7.22	6.31	5.07	3.36
Share Capital ⓘ	3	3	3	3	3	3	3	3	3	3
Reserves ⓘ	2.53	3.92	4.63	5.66	6.26	5.79	4.22	3.31	2.06	0.36
Debt +	0.05	0	0	0	0	0	0	0	0	0
Long Term Debt	0.05	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	4.95	6.82	11.23	10.35	8.59	2.66	4.05	6.47	5.67	8.24
Others Liabilities ⓘ	3.40	3.25	3.63	3.45	2.37	2.27	1.89	1.59	3.39	8.37
Total Liabilities ⓘ	13.93	16.98	22.49	22.45	20.22	13.72	13.16	14.37	14.13	19.97
Fixed Assets
Net Fixed Assets ⓘ +	0.24	0.25	0.22	0.19	0.18	0.14	0.39	0.37	0.33	0.46
Gross Block	0.32	0.36	0.36	0.36	0.38	0.38	0.67	0.77	0.78	1.02
Accumulated Depreciation	0.08	0.10	0.14	0.17	0.20	0.24	0.29	0.40	0.45	0.56
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0.03	0	0	0	0	0	0	0	0	0
Inventories	0.50	0.37	0.35	0.34	0.39	0.26	4.72	4.79	6.02	10.47
Trade Receivables	9.20	13.02	15.05	16.46	15	9.28	2.81	5.32	3.88	3.41
Cash Equivalents	0.17	2	0.40	0.54	0.40	0.40	0.22	0.44	0.40	0.20
Others Assets ⓘ	3.79	1.34	6.47	4.92	4.26	3.65	5.02	3.45	3.50	5.43
Total Assets ⓘ	13.93	16.98	22.49	22.45	20.22	13.72	13.16	14.37	14.13	19.97

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.05	1.37	-1.54	0.21	-0.08	0.03	0.19	0.32	-0.03	0.05
PBT ⓘ	1.30	1.76	1.96	1.81	0.82	-0.36	-2.12	-0.41	-1.54	-1.80
Adjustment ⓘ	0.13	2.20	0.09	0.15	0.10	0.15	0.19	0.07	0.06	0.16
Changes in Working Capital ⓘ	-1.02	-1.83	-2.31	-0.93	-0.76	0.51	2.12	0.65	1.46	1.69
Tax Paid ⓘ	-0.36	-0.76	-1.29	-0.82	-0.23	-0.28	0	0.01	0	0
Cash Flow From Investing Activity ⓘ +	-0.08	0.57	-0	-0	-0.02	0	-0.30	-0.10	-0.01	-0.24
Capex	0	-0.03	-0	-0	-0.02	0	-0.30	-0.10	-0.01	-0.24
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.08	0.61	0	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	-0.05	-0.11	-0.06	-0.06	-0.05	-0.04	-0.06	-0.01	-0	-0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.05	-0.05	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.10	-0.07	-0.06	-0.06	-0.05	0	-0.06	-0.01	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	-0.04	0	0	0	0
Net Cash Flow ⓘ	-0.08	1.83	-1.60	0.15	-0.14	-0	-0.17	0.21	-0.04	-0.20

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	18.15	22.39	17.62	16.37	6.6	-6.1	-20.53	-12.83	-21.93	-41.3
ROCE (%)	26.39	29.04	27.75	23.03	9.74	-3.57	-25.66	-5.94	-26.12	-42.59
Asset Turnover Ratio	3.36	3.92	2.83	2.9	2.33	2.06	0.64	1.61	1.16	0.79
PAT to CFO Conversion(x)	0.05	0.99	-1.2	0.16	-0.14	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	71.70	67	91.90	88.20	115.70	126.70	255.90	66.70	101.80	98.90
Inventory Days	5.90	2.60	2.40	1.90	2.70	3.40	105.40	78.10	119.60	223.40
Payable Days	52.90	41.20	67.40	67.30	82.10	68.40	186	100.10	154.30	212.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Brawn Biotech Ltd FAQs

The current trading price of Brawn Biotech on 12-Jun-2026 16:59 is ₹19.50.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Jun-2026 the market cap of Brawn Biotech stood at ₹5.85 Cr

The latest P/E ratio of Brawn Biotech as of 11-Jun-2026 is 6.22.

The latest P/B ratio of Brawn Biotech as of 11-Jun-2026 is 1.35.

The 52-week high of Brawn Biotech is ₹24.37 and the 52-week low is ₹16.15.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Brawn Biotech is ₹16.98 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Brawn Biotech Ltd is a average quality company.

The key valuation ratios of Brawn Biotech Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Brawn Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Brawn Biotech Ltd

Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other companyâ€™s loan license basis. The company is located in New Delhi, India.

Business Profile:

The company involves in the manufacture, contract manufacture, and supply of pharmaceutical products. It is basically engages in the manufacture of tablets, capsules, and oral syrups.

Products of the company

Company's products are made under various categories namely Analgesics, Antibiotics, Anti Tuberculosis, Anti-inflammatory, Antipyretic, Anti Malarial, B Complex and Amino Acids, Cardiovascular drugs, Antiphyscotropic drugs, Tranquilizers, Antacids.

Brawn Biotech Ltd (530207)

Brawn Biotech Ltd (530207)

Brawn Biotech stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Brawn Biotech - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Brawn Biotech Ltd FAQs

About Brawn Biotech Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Brawn Biotech Ltd (530207)

Brawn Biotech Ltd (530207)

Brawn Biotech stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Brawn Biotech - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Brawn Biotech Ltd FAQs

What is the share price of Brawn Biotech?

What is the market cap of Brawn Biotech?

What is the P/E ratio of Brawn Biotech?

What is the P/B ratio of Brawn Biotech?

What is the 52-week high and low of Brawn Biotech?

What is the TTM revenue of Brawn Biotech?

Is Brawn Biotech Ltd a good quality company?

Is Brawn Biotech Ltd undervalued or overvalued?

Is Brawn Biotech Ltd a good buy now?

About Brawn Biotech Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.